Overview
Value based oncology emphasizes imaging that directly informs treatment decisions and improves patient outcomes while avoiding low value studies. Radiology contributes by selecting appropriate modalities, standardizing protocols and providing quantitative biomarkers for response assessment. Collaboration with oncology teams ensures imaging supports value metrics such as survival, toxicity reduction and quality of life.
Imaging Pathways
Define imaging pathways that specify modality, timing and criteria for surveillance versus active treatment monitoring to reduce unnecessary scans. Use evidence based appropriateness criteria and embed decision support in order entry to guide clinicians. Tailor pathways for curative, adjuvant and palliative contexts to align with goals of care.
Quantitative Endpoints
Adopt validated quantitative imaging biomarkers and standardized response criteria to enable objective assessment of therapy benefit. Centralized reading and automated volumetrics reduce variability in multicenter trials and routine care. Link imaging endpoints to clinical registries to demonstrate real world effectiveness and cost impact.
Payment and Policy
Engage payers and institutional leaders to align reimbursement with value based imaging and to pilot bundled payment models that include imaging endpoints. Provide data on utilization, outcomes and cost savings to support favorable coverage decisions. Use pilot programs to demonstrate feasibility and refine metrics for broader adoption.